BioSpace News Archive

NanoCellect Biomedical Inc., a leader in the development and manufacture of innovative tools for cell analysis and sorting, announces a new travel award program designed to stimulate novel application of the company’s cell sorting technology.

Medical aesthetics manufacturer also reintroduces TempSure™ Vitalia hand piece and continues to market MonaLisa Touch® laser

PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2018.

AstraZeneca and MedImmune, its global biologics research and development arm, have presented overall survival (OS) and progression-free survival (PFS) data from the Phase III MYSTIC trial at the European Society for Medical Oncology (ESMO) Immuno-Oncology 2018 Congress in Geneva, Switzerland.

Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced that it has signed a long-term lease agreement to build-out a gene therapy manufacturing facility in Fremont, California

Rebecca Willumson, publisher of Fierce Biotech, announced today that Life Lua Technologies Inc., a subsidiary of Life Biosciences Inc., has been named the recipient of the Fierce Innovation Award, Life Sciences Edition, in the Digital Health Solutions Category.

Add New Revenue Streams To Your Practice

Gateway Spine & Pain Physicians is a Multi-Disciplinary Pain Management Practice serving the Greater Chicago region with offices in Bolingbrook, Hinsdale, and Downers Grove.

Emerald Textiles today announces the acquisition of the assets of MediClean Linen and Laundry, a Los Angeles-based healthcare linen service provider.

Please note that the below is a corrected version of the news release previously disseminated December 13th at 5pm. Beleave Inc. has advised that changes were made to the third and fourth paragraphs.